Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate Carrieri et al. Metabolism; September 2015 Objective We investigated the effect of glatiramer The following content is accessible for members only, please sign in.